Bausch Health Companies (TSE:BHC) Announces Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Bausch Health Companies (TSE:BHC) released its earnings results on Wednesday. The company reported C$1.53 earnings per share for the quarter, beating the consensus estimate of C$1.43 by C$0.10, reports. The company had revenue of C$3.42 billion for the quarter, compared to the consensus estimate of C$3.36 billion. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%.

Bausch Health Companies Price Performance

TSE:BHC opened at C$12.81 on Friday. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of 7,583.76. The business’s 50-day simple moving average is C$9.82 and its two-hundred day simple moving average is C$9.87. The stock has a market cap of C$4.70 billion, a PE ratio of -7.32, a P/E/G ratio of 0.21 and a beta of 0.77. Bausch Health Companies has a 52 week low of C$5.45 and a 52 week high of C$15.43.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Raymond James upgraded Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 10th. Evercore ISI upgraded Bausch Health Companies to a “hold” rating in a research report on Tuesday, October 15th.

Insider Buying and Selling at Bausch Health Companies

In other Bausch Health Companies news, Senior Officer Seana Lynne Carson sold 13,370 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of C$8.38, for a total transaction of C$112,087.40. Insiders own 11.28% of the company’s stock.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.